The story of Sildenafil presents a intricate picture for investors. While the initial introduction generated significant returns, the end of its intellectual property protection opened the door to generic versions, https://umairwiys794912.timeblog.net/77713992/sildenafil-and-the-pharmaceutical-industry-a-risky-investment